CSRC Vice Chairman Li Chao: Accelerate the research and planning of the strategic tasks and major measures for the capital market during the 14th Five-Year Plan period

The China Securities Regulatory Commission (CSRC) is intensifying its efforts to outline a blueprint for the development of the capital market for the next five-year plan period.

On October 28, CSRC Vice Chairman Li Chao stated at the listing ceremony for the first batch of newly registered companies in the Sci-Tech Innovation Board's growth tier that the China Securities Regulatory Commission will promptly study and plan the strategic tasks and major measures for the capital market during the "14th Five-Year Plan" period, firmly grasping the main line of risk prevention, strengthening regulation, and promoting high-quality development, and unswervingly following the path of financial development with Chinese characteristics.

Li Chao emphasized that the comprehensive reform of capital market investment and financing will be the driving force to comprehensively promote the implementation of a new round of capital market reform and opening up, continuously enhancing the inclusiveness, adaptability, attractiveness, and competitiveness of China's capital market.

The regulatory authorities plan to continuously improve the system's inclusiveness and adaptability through reforms, and to improve the capital market functions that coordinate investment and financing.

The Role of the Sci-Tech Innovation Board as a "Test Field" is Becoming More Apparent

Li Chao stated that the reform "test field" role of the Sci-Tech Innovation Board is becoming increasingly apparent, leading to the continuous improvement of the basic systems across the entire market.

Li Chao put forward specific requirements for companies and market institutions on the Sci-Tech Innovation Board. He hopes that companies on the Sci-Tech Innovation Board will make good use of reform policies, improve corporate governance, and enhance development quality and investor returns.

At the same time, Li Chao hopes that industry institutions will further enhance their professional capabilities and practice quality to better serve real enterprises and investors.

In his speech, Li Chao stated that the Sci-Tech Innovation Board has effectively supported a number of high-tech enterprises in fields such as integrated circuits and biomedicine, and the strong momentum for serving technological innovation is accelerating.

The First Batch of Newly Registered Companies in the Sci-Tech Innovation Board's Growth Tier is Listed Today

According to CCTV reports, the first three newly registered companies in the Sci-Tech Innovation Board's growth tier officially landed on the Sci-Tech Innovation Board today. This comes just 4 months and 10 days after the China Securities Regulatory Commission announced the establishment of the growth tier on the Sci-Tech Innovation Board.

Among the first three newly registered companies in the Sci-Tech Innovation Board's growth tier, two are high-tech enterprises in the biomedicine field, and the other is from the semiconductor materials field, all of which are unprofitable companies.

In June of this year, the China Securities Regulatory Commission announced the establishment of the growth tier on the Sci-Tech Innovation Board, focusing on serving technology-based enterprises that have made significant breakthroughs, have broad commercial prospects, and have substantial ongoing R&D investments, but are currently still in an unprofitable stage.

Since the beginning of this year, 11 companies have been listed on the Sci-Tech Innovation Board, with IPO financing amounting to 16.95 billion yuan, a year-on-year increase of 54%.

Risk Warning and Disclaimer

The market has risks, and investment requires caution. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial conditions, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk